Saturday, October 31, 2026

Groupon Stock Over 30% Up In The Last 21 Sessions

Groupon Stock Over 30% Up In The Last 21 Sessions

Groupon (NASDAQ: GRPN), a Chicago-based online marketplace, has been a subject of discussion due to its remarkable financial journey recently. We witnessed an astonishing 30.2% spike in just 21 sessions from its initial price of $0.06 on July 6, 2023, to 17.21 EST Friday as per 17:21 ET. This tremendous growth outclassed its peers' performance on NASDAQ, which noted a decline of 0.36% and registered three consecutive losses for three sessions continuously.

Groupon's Operation and Market Performance

The corporation, headquartered in Chicago, operates by bridging consumers and merchants online. It deals with services and goods provided by third parties and its own inventory. Despite the recent market uplift, Groupon's last close was still 47.54% below its 52-week high of .85.

Groupon's Financial Health and Profitability Metrics

On the contrary to its market performance, Groupon's financial health and profitability metrics paint a disappointing image. The corporation reported an unsustainable negative return on equity of -285.15% over its trailing twelve-month period. This figure indicates significant losses for every dollar of the accumulated shareholders' equity. Moreover, Groupon's earnings per share (EPS) averaged 8.9 over the same timeframe (TTM).

Future Growth Prospects for Groupon

Yet, the growth forecasts for the organization look hopeful. Analysts predict the corporation's growth to reach 47.1% and 108.8% for the current and the forthcoming quarters, respectively.

Groupon's Trading Volume and Revenue Growth

However, Groupon failed to live up to expectations concerning its trading volume. Its most recently reported volume was just 755,973, or 57% below its average volume of 1,432,950. The revenue growth of the corporation also signals a cause for concern. It suffered a year-on-year decline of 20.7% and stands currently at $567.38 million for its trailing 12-month period. Further intensifying the issue, EBITDA took a downturn from a positive -26.49 to a negative of 26.49, indicating the inability to generate profit from its operations.

What It Means for Investors

Short-term investors might be delighted with the sudden stock gain of Groupon. However, its negative equity return, declining volume, dropping revenue growth, and negative EBITDA could rattle the nerves of long-term investors. Despite these issues, Groupon's strong projected growth can offer some palliation.

More news about Groupon (GRPN).

ViaNews Editorial Team

Via News Editorial Team delivers comprehensive financial news coverage and market analysis from journalists around the world. Our team specializes in data journalism and in-depth reporting on stock markets, business developments, and economic trends.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
ESMO 2026 Oncology Catalyst Cluster: Ivonescimab's PDUFA Date and Small-Cap Biotech Delistings
ESMO 2026 (Oct 22-24) concentrates a wave of oncology readouts. Summit's ivonescimab (10 presentations, positive HARMONi-GI1 OS, new EA2251 Phase II/III with ECOG-ACRIN) leads, ahead of its FDA PDUFA date of 2026-11-14, and Daiichi Sankyo's DXd ADC platform (REJOICE-Ovarian, DESTINY-Lung04, TUXEDO-3) follows. At the other end of the capital-markets spectrum, micro-cap Spago Nanomedical is moving to delist from Nasdaq First North (board resolution Oct 22, EGM Nov 19, application Jan 2027). Pivotal data and regulatory milestones are rewarding well-funded late-stage players, while cash-constrained early-stage developers are exiting public markets.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,995
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,995 facts checked against source5,525 source documents archived
Query this data → isubstrate.com